Janus Henderson Group PLC Sells 7,700 Shares of Healthcare Realty Trust Incorporated (NYSE:HR)

Janus Henderson Group PLC lowered its stake in Healthcare Realty Trust Incorporated (NYSE:HR) by 4.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 171,800 shares of the real estate investment trust’s stock after selling 7,700 shares during the quarter. Janus Henderson Group PLC’s holdings in Healthcare Realty Trust were worth $2,913,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Blue Trust Inc. increased its position in shares of Healthcare Realty Trust by 130.3% in the fourth quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust’s stock worth $30,000 after purchasing an additional 925 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in shares of Healthcare Realty Trust by 59.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 612 shares during the last quarter. Synergy Investment Management LLC purchased a new stake in shares of Healthcare Realty Trust during the 4th quarter valued at $36,000. Jones Financial Companies Lllp lifted its holdings in shares of Healthcare Realty Trust by 68.7% during the 4th quarter. Jones Financial Companies Lllp now owns 3,067 shares of the real estate investment trust’s stock worth $52,000 after acquiring an additional 1,249 shares during the last quarter. Finally, Lee Danner & Bass Inc. purchased a new position in Healthcare Realty Trust in the fourth quarter worth $85,000.

Healthcare Realty Trust Trading Down 0.9%

HR opened at $14.99 on Wednesday. Healthcare Realty Trust Incorporated has a 12 month low of $14.45 and a 12 month high of $18.90. The business’s 50-day moving average price is $15.80 and its 200-day moving average price is $16.59. The company has a market cap of $5.27 billion, a P/E ratio of -8.42 and a beta of 0.92.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings results on Thursday, May 1st. The real estate investment trust reported $0.39 EPS for the quarter, hitting analysts’ consensus estimates of $0.39. The business had revenue of $288.86 million for the quarter, compared to analysts’ expectations of $297.39 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The business’s quarterly revenue was down 9.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.39 EPS. Equities research analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 23rd. Shareholders of record on Monday, May 12th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 8.27%. The ex-dividend date is Monday, May 12th. Healthcare Realty Trust’s dividend payout ratio (DPR) is presently -113.76%.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 13th. The stock was bought at an average price of $14.71 per share, for a total transaction of $36,775.00. Following the completion of the acquisition, the director now directly owns 56,502 shares in the company, valued at $831,144.42. The trade was a 4.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on HR shares. StockNews.com upgraded Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Wednesday. Wedbush decreased their price objective on Healthcare Realty Trust from $18.00 to $16.00 and set a “neutral” rating on the stock in a report on Monday, May 5th. Scotiabank cut their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating for the company in a research note on Tuesday, February 25th. Finally, Wells Fargo & Company reduced their price target on shares of Healthcare Realty Trust from $17.00 to $16.00 and set an “underweight” rating on the stock in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to data from MarketBeat.com, Healthcare Realty Trust presently has a consensus rating of “Hold” and a consensus price target of $17.00.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.